Actively Recruiting
Effects of Arbaclofen on Brain Activity and Behavior in Children and Adolescents with Autism Spectrum Disorders A Randomized, Double-blind, Placebo-controlled Crossover Study Followed by a 10-Week Open-label Treatment
Led by Hospital General Universitario Gregorio Marañon · Updated on 2026-06-17
103
Participants Needed
5
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the effects of arbaclofen on children and adolescents with Autism Spectrum Disorders. This study is a Phase 3 trial that evaluates how arbaclofen impacts brain activity measured by EEG and ERG, and how these changes relate to social and general functioning, adaptive behavior, social anxiety, sensory behaviors, global functioning, and quality of life. The study is sponsored by Hospital General Universitario Gregorio Maraon. Participants will receive an initial single dose of arbaclofen or a placebo in a randomized, double-blind, crossover design. The study includes 4 weeks of dose titration followed by 6 weeks of stable treatment with arbaclofen in an open-label phase lasting 10 weeks. The study measures changes in brain wave power in various frequency bands and clinical responses over the treatment period. During the study, participants will undergo assessments including EEG and ERG recordings, clinical evaluations of social responsiveness, adaptive behavior, and anxiety levels. These assessments occur between baseline and day 7, and from baseline to the end of treatment. Participants will be monitored for safety and treatment effects throughout the study, which spans from initial dosing through the 10-week active treatment phase.
CONDITIONS
Brief Title
Single Dose Double-blind, Placebo-controlled Cross-over (SDDBPCCO) Shiftability Study, Will be Followed by a 10-week Open-label Study With Arbaclofen (4 Weeks of Titration and Then 6 Weeks of Active/Stable Treatment). The Effects of Arbaclofen on Target EEG and ERG Metrics Will be Associated With th
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here